These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 857429

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Methodology and clinical significance of heparin cofactor II. Probable heparin cofactor II deficiency in a patient with cerebrovascular thrombosis.
    Tran TH, Zbinden B, Lämmle B, Duckert F.
    Semin Thromb Hemost; 1985 Oct; 11(4):342-6. PubMed ID: 3840916
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex].
    von Felten A.
    Ther Umsch; 1992 Dec; 49(12):837-42. PubMed ID: 1485282
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
    Martinelli I, Cattaneo M, Panzeri D, Mannucci PM.
    Thromb Haemost; 1997 Mar; 77(3):440-3. PubMed ID: 9065990
    [Abstract] [Full Text] [Related]

  • 50. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C, Wolf M, Vedrenne J, Meyer D, Larrieu MJ.
    Thromb Haemost; 1986 Aug 20; 56(1):18-22. PubMed ID: 3775688
    [Abstract] [Full Text] [Related]

  • 51. [A case of familial antithrombin III variant complicated by recurrent pulmonary infarction].
    Nakano Y, Sato A, Okano A, Chida K, Yasumi T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb 20; 31(2):214-8. PubMed ID: 8515601
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Hereditary antithrombin III deficiency and pregnancy: report of two cases and review of the literature.
    Nelson DM, Stempel LE, Brandt JT.
    Obstet Gynecol; 1985 Jun 20; 65(6):848-53. PubMed ID: 4039808
    [Abstract] [Full Text] [Related]

  • 55. [Hereditary antithrombin III deficiency as a cause of an increased tendency to thrombosis. Case report].
    Brunner W, Hartmann G.
    Schweiz Med Wochenschr; 1985 Mar 09; 115(10):343-5. PubMed ID: 3983586
    [Abstract] [Full Text] [Related]

  • 56. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M, Fukuoka N, Nishiyama T, Maekawa S, Shirakawa Y.
    Shock; 2007 Aug 09; 28(2):141-7. PubMed ID: 17515857
    [Abstract] [Full Text] [Related]

  • 57. [Anti-coagulant therapy--antithrombin III].
    Tsuji H.
    Rinsho Ketsueki; 1990 Jun 09; 31(6):750-5. PubMed ID: 2214165
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J.
    Dan Med Bull; 1988 Feb 09; 35(1):1-33. PubMed ID: 3277796
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.